China Pharma Holdings (CPHI) Goodwill & Intangibles (2010 - 2026)
China Pharma Holdings' (CPHI) quarterly Goodwill & Intangibles came in at $38.7 million in Q1 2026, up 488.66% YoY from $6.6 million in Q1 2025, and up 60.61% on a QoQ basis from $24.1 million in Q4 2025.
China Pharma Holdings (CPHI) Goodwill & Intangibles (2010 - 2026) Analysis & Trends
China Pharma Holdings (CPHI) has 17 years of Goodwill & Intangibles data on file, last reported at $38.7 million in Q1 2026.
- Quarterly Goodwill & Intangibles rose 488.66% year-over-year to $38.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $38.7 million (up 488.66% YoY) and the FY2025 annual result came in at $24.1 million, up 273.64% from the prior year.
- Goodwill & Intangibles advanced to $38.7 million in Q1 2026, from $24.1 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $38.7 million in Q1 2026 to a low of $106788.0 in Q3 2022.
- A 5-year average of $6.7 million and a median of $4.4 million in 2024 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2022 — Goodwill & Intangibles tumbled 97.95% — and 2023, when it jumped 1437.96%.
- Tracing CPHI's Goodwill & Intangibles over 5 years: stood at $1.8 million in 2022, then surged by 80.1% to $3.3 million in 2023, then jumped by 97.97% to $6.4 million in 2024, then soared by 273.64% to $24.1 million in 2025, then surged by 60.61% to $38.7 million in 2026.
- The last three Goodwill & Intangibles figures came in at $38.7 million (Q1 2026), $24.1 million (Q4 2025), and $8.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - |
| 10 | China Pharma Holdings | 41.38 Mn | 41.08 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.67 Mn |
| Dec 31, 2025 | 24.08 Mn |
| Sep 30, 2025 | 8.45 Mn |
| Jun 30, 2025 | 6.44 Mn |
| Mar 31, 2025 | 6.57 Mn |
| Dec 31, 2024 | 6.44 Mn |
| Sep 30, 2024 | 4.36 Mn |
| Jun 30, 2024 | 4.39 Mn |
| Mar 31, 2024 | 4.52 Mn |
| Dec 31, 2023 | 3.26 Mn |
| Sep 30, 2023 | 1.64 Mn |
| Jun 30, 2023 | 1.68 Mn |
| Mar 31, 2023 | 1.83 Mn |
| Dec 31, 2022 | 1.81 Mn |
| Sep 30, 2022 | 106,788.00 |
| Jun 30, 2022 | 122,127.00 |
| Mar 31, 2022 | 138,798.00 |
| Dec 31, 2021 | 147,841.00 |
| Sep 30, 2021 | 5.21 Mn |
| Jun 30, 2021 | 164,942.00 |